MRK Stock Recent News

The premise makes enough sense on the surface. Not only does a higher dividend yield mean more income per invested dollar, it may also mean the stock in question is undervalued and ripe for a rebound.

These 4 dividend stocks have generated steady passive income for investors for many years.

In the current tech-heavy market, I explore two compelling value stocks with strong yields and trade at deep discounts to historical valuations. Both have competitive advantages and strong histories of capital returns to shareholders. Both appear to be severely mispriced, offering enterprising investors the opportunity to capture value before the market pendulum swings back.

High Noon has issued quite a disturbing recall after Beach Variety 12-pack cases included alcohol-based cans mislabeled as energy drinks. Cans labeled “Celsius Astro Vibe Sparkling Blue Razz” may actually contain vodka. The FDA states that the error arose from a shared supplier mistake. Recalls affect several U.S. states across multiple lot codes. Consumers are being asked to dispose of cans and seek refunds. Though no illnesses have been reported, this error is especially dangerous for alcoholics who consume energy drinks. Another major warning, this time to cracker lovers with nut allergies: Ritz accidentally mislabeled peanut butter crackers as cheese crackers. After realizing the recent error, Mondelez International immediately issued a recall. The recall includes a variety of carton sizes, including 8-, 20-, and 40- count containers. Though outer cartons were labeled correctly, the inner labels were not. The misfire could be dangerous for those with severe nut allergies. Fortu

The S&P 500 (^GSPC -1.60%) is offering investors a tiny yield of just 1.2% today. If you think you are being starved of dividend income, well, that's because you are.

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing globally, the future of gene therapy, changes at FDA, and more.

My watchlist aims to identify high-quality, high-yield stocks trading at attractive valuations, outperforming benchmarks in yield, and offering strong long-term CAGR. The August 2025 Top 10 list remains unchanged from the prior month, featuring an average forward yield of 3.51% and a projected 15.58% expected rate of return. Since its inception, my watchlist has had a CAGR of 15.24%, performing in line with SPY and VYM while providing a superior dividend yield.

CNBC's Joe Kernen reports on the latest news.

U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House said on Thursday.